Introduction {#s1}
============

Intravenous recombinant tissue plasminogen activator (rtPA) is the gold standard therapy for acute ischemic stroke. [@pone.0075378-The1]--[@pone.0075378-Hacke1] It can only be applied up to 4.5 hours within the onset of stroke symptoms [@pone.0075378-Hacke1] and a short onset-to-treatment time (OTT) translates into a better functional outcome [@pone.0075378-Lees1]. The OTT is composed of onset-to-door time (ODT) and door-to-needle time (DNT). The latter is dependent on the process management of each individual hospital and therefore used as a benchmark for the organization of in-hospital acute stroke care. Highly specialized centers have reported to reduce this in-hospital delay to as low as a median of 20 minutes. [@pone.0075378-Meretoja1] Still recent evaluations in the US (Get With The Guidelines Stroke national United States Registry, GWTG-Stroke) [@pone.0075378-Fonarow1] and in Eastern European Countries [@pone.0075378-Mikulik1] (Safe Implementation of Treatments in Stroke -- East Registry, SITS-EAST) have shown only 26.6% and 38% of patients are treated with iv thrombolysis with a DNT below 60 minutes as recommended by national guidelines. Both evaluations demonstrated a high variability between different centers in reaching this goal ranging between 0% to 84%. [@pone.0075378-Fonarow1], [@pone.0075378-Mikulik1] Our own previous analysis of the Austrian Stroke Unit Registry [@pone.0075378-Ferrari1] as well as other evaluations have described multiple factors increasing the DNT like older age, female sex, black race, low or very high stroke severity, presence of prior stroke, short ODT and performing angiography or perfusion imaging prior to thrombolysis [@pone.0075378-Fonarow1], [@pone.0075378-Mikulik1]. Yet all these factors fail to explain the high inter-center variability. [@pone.0075378-Fonarow1], [@pone.0075378-Mikulik1] As possible cause differences in stroke management within stroke centers and countries have been proposed. [@pone.0075378-Mikulik1] In order to further explore factors that influence the DNT with a special focus on process measurements we supplemented the extensive hospital and case level data (like for example age, sex, clinical syndrome or National Institutes of Health Stroke Scale score (NIHSS)) of the Austrian stroke unit registry with information of a structured questionnaire on process measures in all stroke units in Austria.

Methods {#s2}
=======

Since 2003, a growing network of Austrian stroke units have been collecting data on standard characteristics and acute management of all patients with stroke admitted to 34 Austrian stroke units. Data collection and ratings were performed by experienced stroke neurologists using standardized variable definitions and scores. To ensure high quality of data, immediate data entry was obligatory. The web-based database includes online plausibility checks and help. In biannual meetings of stroke neurologists, details about scoring procedures and variable assessment are thoroughly discussed.

In April 2004, the registry was enriched by documentation of the ODT and the DNT, including details and timing of in-hospital management. Definitions of variables in the registry are listed in [Table 1](#pone-0075378-t001){ref-type="table"} and have been described previously [@pone.0075378-Ferrari1]--[@pone.0075378-Knoflach1].
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###### Available variables on patient and center characteristics.

![](pone.0075378.t001){#pone-0075378-t001-1}

  Variable                                                                                                               Levels (the first is used as reference level)
  ---------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------
  **Case-based characteristics**                                   
  Gender                                                                                                                                 male, female
  Age                                                                                                                     (70, 80\], \[0, 60\], (60, 70\], (80, 110\]
  Modified Rankin Scale prior to current event                                                                                         0, 1, 2, 3, 4, 5
  Hypertension                                                                                                                              no, yes
  Diabetes mellitus                                                                                                                         no, yes
  Previous stroke                                                                                                                           no, yes
  Previous heart attack                                                                                                                     no, yes
  Hypercholesteremia                                                                                                                        no, yes
  Atrial fibrillation                                                                                                                       no, yes
  Other cardiac disease                                                                                                                     no, yes
  Peripheral artery disease                                                                                                                 no, yes
  Current smoker                                                                                                                            no, yes
  Onset-to-Door Time                                                                                                       61--120, 0--60, \>120, unknown, (minutes)
  National Institute of Health Stroke Scale                                                                                5--8, 0--4, 9--12, 13--16, 17--20, 21--42
  Etiology                                                                                                  microangiopathy, macroangiopathy, cardiogenic embolism, other, unknown
  Clinical Syndrome                                                 partial anterior circulation stroke (PACS), lacunar stroke (LACS), total anterior circulation stroke (TACS), posterior circulation stroke (POCS), other
  Admission Date                                                                                                            unit: (days since Jan. 1. 2011)/365.25
  Ambulance crew with emergency doctor                                                                                                      no, yes
  Urinary catheter                                                                                                                          no, yes
  Working hours, 8--16 h Monday to Friday                                                                                                   no, yes
  **Hospital -based characteristics**                              
  Pre-notification                                                                                                             \>75%, \< = 25%, 26--50%, 51--75%
  Admission                                                                               directly to stroke unit, to emergency department with neurologist on duty, to general emergency department
  Radiology department                                                                                                                  close, distant
  Routine-imaging                                                                                                                          CT, other
  Who escorts the patient to the radiology department                                                                    porters' services, the doctor on duty, other
  Other investigations                                                                                                                      no, yes
  Wait for blood test                                                                                              no, point of care test, full blood count, other approach
  Weigh the patient                                                                                                                         no, yes
  Where do patients receive thrombolysis                                                                            stroke-unit, general emergency department, on CT table
  Rates of thrombolysis                                                                                     medium (10,20\]%, low ≤10%, high \>20% (of all acute ischemic strokes)
  Individual dummy-variable for each stroke unit (pseudonymized)   

Except the admission date, which is coded as years from January 1, 2011, all variables were dummy-coded with the first category serving as reference level.

To obtain detailed information about variables that affect the DNT in Austria, we designed a structured questionnaire containing 11 questions about possible causes for prolonged DNT, both in the pre-hospital phase and in-hospital phase: (1) What percentage of patients arrive via the pre-notification-system? (\<25%, \<50%, \>50%, \>75%); (2) Where are patients admitted to in hospital? (directly to the stroke unit, straight to the emergency department with the neurologist on duty, to the general emergency department); (3) Is the stroke unit/emergency department with a neurologist on duty located near the radiology department? (yes - in the same building reachable within 2 minutes, no); (4) What is your routine choice of imaging investigation before thrombolysis? (plain head CT, other); (5) Who escorts the patient to the CT/MRI scanner? (porters' services, the doctor on duty, other); (6) Are there any other investigations performed before thrombolysis? (e.g. ultrasound, ...) (yes, specify:..., no); (7) Do you wait for any blood test results to come back for before initiating systemic thrombolysis? (No. If the history does not suggest that the patient is on oral anticoagulation, thrombolysis is immediately started; point of care tests are routinely performed first; we wait for the full blood count to come back first; any other approach (please state)); (8) Do you weigh the patient on a scale? (yes, no);(9) Where do patients receive thrombolysis? (at the general emergency department, on the CT table, at the stroke unit);(10) What is the size of the nursing team available for thrombolysis? (one nurse, two nurses, more than two nurses); (11) Are there any other factors that could potentially delay thrombolysis? (Please explain).

All 34 questionnaires from the 34 stroke units in Austria were returned and were analyzed in a pseudoanonymized way.

Statistical Analysis {#s2a}
--------------------

As a statistical environment R (version 2.11.1) [@pone.0075378-R1] with the package lars [@pone.0075378-Hastie1] was used. The relationship between DNT and several explanatory variables listed in [table 1](#pone-0075378-t001){ref-type="table"} were modeled by a linear regression. Due to the skewed distribution of the DNT, the log-transformed DNT was used as target variable. The variable subset selection was done using the least absolute shrinkage and selection operator (LASSO) procedure. [@pone.0075378-Tibshirani1] For each variable subset along the lasso trace the model was refitted without restriction and the Bayesian Information Criterion (BIC) was computed. The final model optimizes the BIC and has been found to be superior to the stepwise forward and the stepwise backward model.

Standard Protocol Approvals, Registrations, and Patient Consents {#s2b}
----------------------------------------------------------------

The registry is part of a governmental quality assessment program for stroke care in Austria financed by the Federal Ministry of Health. It is based on the federal law promoting quality in health (Gesundheitsqualitätsgesetz). Anonymized data are centrally administrated by the Gesundheit Österreich GmbH and scientific analyses are approved and supervised by an academic review board. Details on this registry have been reported previously [@pone.0075378-Ferrari1]--[@pone.0075378-Knoflach1].

Results {#s3}
=======

Between April 2004 and November 8^th^ 2012, a total of 57991 patients with an acute ischemic stroke were treated in Austrian stroke units. 7498 (13%) of them received a therapy with intravenous thrombolysis. After excluding individuals with a DNT of more than 240 minutes, those with incomplete information about risk factors and modified Rankin scale before admission and individuals with in hospital stroke (ODT ≤0 minutes), 6246 subjects remained and served as the current study population. Baseline characteristics for those with complete dataset are summarized in [Table 2](#pone-0075378-t002){ref-type="table"}. Baseline characteristics for the whole population (n = 7498) do not differ significantly from those with complete dataset (data not shown).
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###### Description of the study population (N = 6246).
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  -------------------------------------------------------------------- ----------------
  Age, years, median (IQR)                                               74 (64, 81)
  Sex, female, N (%)                                                      3305 (53)
  National Institute of Health Stroke Scale (NIHSS), median (IQR)         9 (5, 15)
  Onset-to-Door Time (ODT), minutes, median (IQR)                        75 (50, 106)
  Door-to-needle Time (DNT), minutes, median (IQR)                       48 (35, 67)
  Onset-to-Needle Time (ONT), minutes, median (IQR)                     130 (100, 169)
  Hypertension, N (%)                                                     4935 (79)
  Diabetes mellitus, N (%)                                                1282 (21)
  Previous stroke, N (%)                                                  1056 (17)
  Previous heart attack, N (%)                                             577 (9)
  Hypercholesteremia, N (%)                                               3247 (52)
  Atrial fibrillation, N (%)                                              2039 (33)
  Other cardiac disease, N (%)                                            1345 (22)
  Peripheral artery disease, N (%)                                         316 (5)
  Current smoker, N (%)                                                   1039 (17)
  Prestroke disability (mRS 3--5), N (%)                                   531 (9)
  Thrombolysis during working hours, 8--16 h Monday to Friday, N (%)      2587 (41)
  -------------------------------------------------------------------- ----------------

IQR = interquartile range; mRS = modified Ranking Scale.

The median DNT (2005--2012) in the different centers ranged between 30 and 78 minutes ([Figure 1](#pone-0075378-g001){ref-type="fig"}). The proportion of patients receiving rtPA within 60 minutes of stroke onset increased over the years over all stroke centers in Austria from 59% in 2005 to 76% in 2012. In 2012, median DNT ranged between 26 and 71 minutes. Results of the questionnaire of 34 Austrian stroke units are summarized in [table 3](#pone-0075378-t003){ref-type="table"}.

![Inter center variability of the door-to-needle times in the 34 stroke units in Austria (box-plots).](pone.0075378.g001){#pone-0075378-g001}
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###### Results of questionnaire on process measures in Austrian stroke units (n = 34).

![](pone.0075378.t003){#pone-0075378-t003-3}

  ----------------------------------------------------------------------------------------------------------------- --------
  What percentage of patients arrive via the pre-notification-system?                                               
  \<25%                                                                                                              14.70%
  \<50%                                                                                                              17.60%
  \>50%                                                                                                              26.50%
  \>75%                                                                                                              41.20%
  Where are patients admitted to in hospital?                                                                       
  Directly to the stroke unit                                                                                        32.40%
  Straight to the emergency department with neurologist on duty                                                      29.40%
  To the general emergency department                                                                                38.20%
  Is the stroke unit/emergency department with a neurologist on duty located near the radiology department?         
  Yes                                                                                                                82.40%
  No                                                                                                                 17.60%
  What is your routine choice of imaging investigation before thrombolysis?                                         
  Plain head CT                                                                                                      55.90%
  Other                                                                                                              44.10%
  Who escorts the patient to the CT/MRI scanner?                                                                    
  Porters' services                                                                                                  58.80%
  Doctor on duty                                                                                                     32.40%
  Other                                                                                                              8.80%
  Are there any other investigations performed before thrombolysis? (e.g. ultrasound, ...)                          
  Yes                                                                                                                17.60%
  No                                                                                                                 82.40%
  Do you wait for any blood test results to come back for before initiating systemic thrombolysis?                  
  If the history does not suggest that the patient is on oral anticoagulation thrombolysis is immediately started    23.50%
  Point of care tests are routinely performed                                                                        14.70%
  Wait for the full blood count                                                                                      47.10%
  Other approach                                                                                                     14.70%
  Do you weigh the patient on a scale?                                                                              
  Yes                                                                                                                14.70%
  No                                                                                                                 85.30%
  Where do patients receive thrombolysis?                                                                           
  General emergency department                                                                                       11.80%
  CT scanner                                                                                                         2.90%
  Stroke unit                                                                                                        85.30%
  What is the size of the nursing team available for thrombolysis?                                                  
  One nurse                                                                                                          32.40%
  Two nurses                                                                                                         58.80%
  More than two nurses                                                                                               8.80%
  ----------------------------------------------------------------------------------------------------------------- --------

In a multiple regression model, the impact of defined process measures (according to the structured questionnaire) and patient level data (taken from the Austrian Stroke Unit Registry) on the delay in DNT was quantified. ODT ≤60 minutes, unknown ODT, patients with an NIHSS ≤4 or posterior circulation stroke, initial admission to a general emergency department, a distant radiology department, primary imaging modality other than CT without contrast agent and waiting for the results of the blood count were associated with an increase in DNT whereas an ODT \>120 minutes, patients with total anterior circulation *s*troke, recent year of admission, patient transportation with ambulance crew and emergency physician, the use of point of care tests all reduced the DNT ([Figure 2](#pone-0075378-g002){ref-type="fig"}). Furthermore three centers yielded a significantly different DNT independent of all the factors mentioned above.

![Multiple regression model of case level and center specific factors on the door-to-needle time in Austria.\
The model contains 18 coefficients (including the intercept) and is based on 5858 observations (adjusted R2 0.14). Since the target variable is log(DNT) the coefficients are not additive in terms of the DNT, but the exp(coefficients) are multiplicative factors in relation to the reference value exp(Intercept).](pone.0075378.g002){#pone-0075378-g002}

Discussion {#s4}
==========

Differences in in-hospital delays for the treatment with thrombolysis in different stroke centers is a well described and important, yet unresolved, issue [@pone.0075378-Fonarow1], [@pone.0075378-Mikulik1], especially as delays in treatment translate into an adverse outcome [@pone.0075378-Lees1]. Even though acute stroke care in Austria is highly efficient with shorter OTT and a lower three month mortality than other non-Austrian centers in the SITS registry [@pone.0075378-Topakian1] and with a high proportion of patients treated with rtPA within 60 minutes of arrival to the hospital, we still observe a considerable variability in the DNT between centers.

In accordance with our own and other previous evaluations patient factors like a delay in arrival to the hospital (ODT) and stroke severity influence the DNT. [@pone.0075378-Meretoja1]--[@pone.0075378-Ferrari1] Interestingly other factors previously reported to cause delays in the DNT like age, sex and the number of patients treated with intravenous thrombolysis annually [@pone.0075378-Fonarow1], [@pone.0075378-Mikulik1] did not independently alter the in-hospital delays in Austria.

Our analysis shows that the highest in-hospital delays are associated with imaging. Especially a radiology department distant from the location where the stroke patient is treated and any imaging other than plain CT (in accordance with Meretoja et al [@pone.0075378-Meretoja1]) prolonged the DNT considerably.

Another substantial prolongation of the DNT was associated with lab analyses in our evaluation. Given the low prevalence of coagulation disorders in stroke patients without a clear medical history [@pone.0075378-Rost1] thrombolytic therapy should not be delayed while awaiting the lab resuls unless there is either a clinical suspicion of bleeding or thrombocytopenia or the patient has receiced heparin or warfarin or the use of anticoagulants is known. [@pone.0075378-Adams1] The problem of pretreatment with oral anticoagulation or an unclear medication history can be safely overcome by the use of a point of care device to measure the INR [@pone.0075378-Rizos1].

Interestingly, also in patients with a stroke in the posterior circulation and those with a low stroke severity thrombolysis was delayed. This might be due to the fact that many local thrombolysis protocols cover only hemispheric strokes with an NIHSS of 4 to 25. In addition the NIHSS has been reported to underestimate stroke severity in the posterior circulation [@pone.0075378-Linfante1], [@pone.0075378-Sato1].

Even though we found no association between the experience of a single stroke center and the DNT, this was true in other evaluations [@pone.0075378-Fonarow1]. Still direct presentation of a stroke patient to an experienced team (neurological emergeny department or stroke unit) leads to a significant shorter DNT in Austria. This is especially true for those patients accompanied by an emergency physician. In this context a prenotification system to alarm a stroke team has been shown to be of use [@pone.0075378-Meretoja1], [@pone.0075378-Fonarow2].

Even after correcting for a wide array of process measurements and patient level data, still two stroke units were significantly slower and one significantly faster than all other Austrian centers. We can only hypothize about the possible background like hard to define human factors, lack of resources and referral biases.

Recent literature has shown that interventions aiming to modify processes in acute stroke treatment can [@pone.0075378-Ford1] but not necessarily have to be [@pone.0075378-Scott1] efficient. Therefore changes in process measurements should closely be monitored for their effect on patient care. Upcoming intervention studies [@pone.0075378-Safe1] might help to optimize process measurements.

To the best of our knowledge this is the first study exploring the influence of a combination of center and case specific variables on the DNT of all designated stroke units of a whole country.

The strengths of the study are as follows: First, Austria and its stroke unit network is especially suited to address the questions as the large sample of 57991 patients treated 34 stroke units reflects the acute stroke care of a whole country. Second, bias like incomplete center participation or reduced access to healthcare [@pone.0075378-Lees1] do not apply to our evaluation as all centers of a whole country were included, all of them offering stroke care free of charge due to a general health insurance in Austria.

Our study has several limitations: First, administrative and clinical registries are limited in the details of clinical information. Second, as every designated stroke center aims to improve patient care, process measures are constantly adapted in every stroke unit. The information on center specific processes was obtained in winter 2011. Even though we did not observe above the average drop in DNT in the three centers with unexplained deviations in in-hospital delays for iv thrombolysis over the years, the same factors remained in the model when our analysis was restricted to the years 2011 and 2012 and a clustered analysis of different years showed a similar impact of the different factors in delaying treatment, we cannot exclude that this bias might have influenced our results (data not shown). Third, we do not have data on how many of our stroke patients were not treated with intravenous thrombolysis, because they were admitted to other wards than stroke unit and therefore were not entered in the registry.

Conclusion {#s4a}
----------

The median DNT in Austria has constantly decreased over the years to 48 minutes. The seemingly high inter center variability could largely be explained by differences in process measures and patient factors. Based on our analysis several actions might be useful to reduce the DNT: First of all patients should directly be seen by a neurologist at a specialized stroke unit or neurological emergency department. Optimizing time to CT scan and performing the fastest imaging modality in patients with clear onset of symptoms seems crucial. POC devices (for measurement of INR) or initiating thrombolyis before arrival of the lab results in selected patients can significantly reduce delays created by lab analyses. Furthermore standardized protocols, especially for groups of patients with syndromes or conditions leading to uncertainties and thereby to delays, like for example patients with a stroke in the posterior circulation or a low NIHSS, might be useful. One should keep in mind that stroke evaluation and treatment has top priority independent of the ODT. The latter can substantially reduced by education of dispatchers and emergency system. In conclusion, we highly recommend a continuous quality assessment in the context of acute stroke treatment and a regular lively intra- and intercenter discussion of possibilities to optimize processes and patient care. Further studies might be useful to identify interventions and process modifications most suitable to reduce the DNT and to stimulate a global change in the treatment of acute stroke.
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